Notizie Theriva Biologics - TOVX

Ultime notizie

Data	Ora	Fonte	Titolo
23/5/2024	14:20	EDGAR2	Form 8-K - Current report
16/5/2024	13:30	EDGAR2	Form 8-K - Current report
07/5/2024	13:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/2024	13:05	EDGAR2	Form 8-K - Current report
07/2/2024	14:10	EDGAR2	Form 8-K - Current report
08/1/2024	14:10	EDGAR2	Form 8-K - Current report
15/12/2023	22:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
15/12/2023	22:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
15/12/2023	22:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
15/12/2023	22:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
13/11/2023	14:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
23/10/2023	13:10	EDGAR2	Form 8-K - Current report
17/10/2023	12:05	EDGAR2	Form 8-K - Current report
03/10/2023	12:06	EDGAR2	Form 8-K - Current report
16/8/2023	23:24	EDGAR2	Form DEFR14A - Revised definitive proxy soliciting materials
15/8/2023	15:53	EDGAR2	Form ARS - Annual Report to Security Holders
14/8/2023	23:11	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/8/2023	22:30	EDGAR2	Form 8-K - Current report
08/8/2023	15:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/2023	14:10	EDGAR2	Form 8-K - Current report
02/8/2023	15:22	EDGAR2	Form 8-K - Current report
28/6/2023	16:15	APS	Another Biotech Stealing The Premarket Spotlight

Apertura:	Min:	Max:
Chiusura: 0,263